Maternal Prepregnancy BMI, Birth Length Linked to Offspring Atopic Dermatitis
Medically reviewed by Drugs.com
via HealthDayFRIDAY, April 10, 2026 -- Increasing maternal prepregnancy body mass index (ppBMI) and increasing birth length are associated with offspring atopic dermatitis by age 3 years, according to a study published online March 23 in the Journal of Allergy and Clinical Immunology: Global.
Frida Berents, from the University of Bergen in Norway, and colleagues examined whether ppBMI and offspring newborn anthropometric measures or fetal growth are associated with atopic dermatitis by age 3 years. Maternal ppBMI was reported at enrollment at midpregnancy in 2,107 mother-child pairs from the general population-based Scandinavian Preventing Atopic Dermatitis and ALLergies cohort. Standard criteria were used to diagnose atopic dermatitis at ages 3, 6, 12, 24, and 36 months.
The researchers found that by age 3 years, atopic dermatitis was diagnosed in 525 of 2,107 children (25 percent), with a positive association seen with increasing maternal BMI (adjusted odds ratio per BMI unit, 1.03; 95 percent confidence interval, 1.00 to 1.06). There was a positive association for increasing birth length with atopic dermatitis (adjusted odds ratio, 1.06; 95 percent confidence interval, 1.01 to 1.12), while an inverse association was seen for short birth length (<48 cm; adjusted odds ratio, 0.71; 95 percent confidence interval, 0.51 to 1.00). There were no associations observed for birth weight; thoracic, abdominal, or upper arm circumference at birth; or fetal growth with atopic dermatitis.
"Our results highlight the importance of early-life growth patterns for the development of atopic dermatitis," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-11 01:45
Read more
- Higher Meat Intake Tied to Better Cognitive Trajectories in Genetic Risk Group
- Study Links High Antioxidant Intake To Changes in Offspring Development
- AAD: Upadacitinib Safe, Effective for Nonsegmental Vitiligo
- AHA: Five-Year Risk for Prediabetes Progression Varies in Young Adults
- Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
- Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. Approval for Opdivo (nivolumab)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions